National Institute for Health and Care Excellence (NICE)
- EGFR-TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer.
- Gene expression profiling and expanded immunohistochemistry tests for guiding adjuvant chemotherapy decisions in early breast cancer management: MammaPrint, Oncotype DX, IHC4 and Mammostrat.
- Intraoperative tests (RD-100i OSNA system and Metasin test) for detecting sentinel lymph node metastases in breast cancer.
No hay comentarios:
Publicar un comentario